Skip to main content

908 Devices Inc

For the period ended Mar 31, 2024. Filed May 3, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 3, 2024

MASS$9.99-13.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

(In thousands)

​​​​​​​
​ · ​ · Three Months Ended March 31,
​ · 2024 · 2023
Cash flows from operating activities: · ​ · ​ · ​ · ​
Net loss​$(10,917)​$(12,532)
Adjustments to reconcile net loss to net cash used in operating activities:​​​​
Depreciation and amortization expense​1,328​634
Stock-based compensation expense​2,643​2,166
Noncash interest expense and loss on extinguishment of debt​—​523
Provision for inventory obsolescence​151​—
Net amortization of premiums and accretion of discounts on marketable securities​​(92)​​—
Loss on sale of property and equipment​​28​​—
Provision for credit losses​​25​​—
Change in fair value of contingent consideration​​—​​166
Deferred income tax​​(70)​​(50)
Changes in operating assets and liabilities:​​​​
Accounts receivable, net​1,460​1,873
Inventory​(1,675)​(990)
Prepaid expenses and other current assets​343​(1,492)
Other long-term assets​42​7
Accounts payable and accrued expenses​(1,771)​(339)
Deferred revenue​(841)​(123)
Right-of-use operating lease assets​470​299
Operating lease liabilities​(481)​(353)
Other long-term liabilities​—​​(436)
Net cash used in operating activities​(9,357)​(10,647)
Cash flows from investing activities:​​​​
Purchases of property and equipment​(903)​(1,185)
Purchases of marketable securities​​(14,617)​​—
Proceeds from sales and maturities of marketable securities​​9,740​​—
Net cash used in investing activities​(5,780)​(1,185)
Cash flows from financing activities:​​​​
Payments for withholding taxes on vested awards​​(939)​​(469)
Proceeds from issuance of common stock​​61​​88
Repayment on revolving line of credit​​—​​(15,000)
Payments for contingent consideration​​(417)​​—
Net cash used in financing activities​(1,295)​(15,381)
Effect of foreign exchange rate changes on cash and cash equivalents​​(10)​​5
Net decrease in cash, cash equivalents and restricted cash​(16,442)​(27,208)
Cash, cash equivalents and restricted cash at beginning of period​121,212​188,593
Cash, cash equivalents and restricted cash at end of period​$104,770​$161,385
Supplemental disclosure of noncash investing and financing information:​​​​
Property and equipment included in account payable​$—​$35
Transfers of inventory to property and equipment​$91​$133
Reconciliation of cash, cash equivalents and restricted cash:​​​​​​
Cash and cash equivalents​$104,599​$161,214
Restricted cash included in prepaid expenses and other current assets​​—​60
Restricted cash included in other long-term assets​​171​​111
Total cash, cash equivalents and restricted cash shown in the statement of cash flows​$104,770​$161,385
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.